Bayer announced the FDA approved finerenone, a nonsteroidal selective mineralocorticoid receptor antagonist, for the ...

In this paper, we focus on the issue of Couple Noisy Labels (CNL) in Visible-Infrared Person Re-identification. CNL which refers to the Noisy Annotations and the Noisy Correspondences. Existing ...

Upadacitinib demonstrated greater clinical efficacy and a comparable safety profile to adalimumab for treating RA, regardless of patients’ baseline CV risks.